NICE recommends treatment with Strimvelis for adenosine deaminase deficiency severe combined immunodeficiency.- GlaxoSmithKline.
According to final guidance from NICE, Strimvelis (gene therapy), from GlaxoSmithKline, is recommended, within its marketing authorisation, as an option...